Terapia de inicio con infliximab en una vasculitis oclusiva bilateral como inicio de una enfermedad de Behçet
- P. Bañeros-Rojas
- C. Berrozpe-Villabona
- J.E. Peraza-Nieves
- D. Díaz-Valle 1
- 1 Universidad Complutense de Madrid 920415-GR58/08, Madrid, España (Grupo de investigacion)
ISSN: 0365-6691
Year of publication: 2015
Volume: 90
Issue: 6
Pages: 285-288
Type: Article
More publications in: Archivos de la Sociedad Española de Oftalmologia
Sustainable development goals
Abstract
Case report A 24 year old woman who complained of maculo-papulo rash, genital and bucal aphthous ulcers, abdominal pain, minor dyspnea and visual loss in both eyes. Funduscopy revealed a bilateral occlusive vasculitis including central vessels. Treatment was initiated with a methylprednisolone bolus (1 g/24 h) and infliximab 5 mg/kg/day (0-2-6 weeks and every 8 weeks). The treatment prescribed induced a fast remission. Visual acuity improved. The patient did not suffer any other relapse after one year of follow-up. Discussion An initial treatment with Infliximab should be considered in Behçet disease for serious outbreaks, such as macular occlusive vasculitis with ischemia.